Skip to search formSkip to main contentSkip to account menu

PYY3 gene

Known as: OTTHUMG00000021515, PYY3, peptide YY, 3 (pseudogene) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes
There is an unmet need for a safer and more effective treatment for obesity. This study assessed the effects of licogliflozin, a… 
Highly Cited
2010
Highly Cited
2010
Gut Hypertrophy After Gastric Bypass Is Associated With Increased Glucagon-Like Peptide 2 and Intestinal Crypt Cell Proliferation
Objective:We aimed to determine changes in crypt cell proliferation and glucagon-like peptide-2 (GLP-2) in rodents and man after… 
Highly Cited
2007
Highly Cited
2007
Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects.
Peptide YY (PYY)(3-36) has been shown to produce dramatic reductions in energy intake (EI), but no human data exist regarding… 
Highly Cited
2007
Highly Cited
2007
Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males.
Intraveneous (i.v.) PYY(3-36) infusions have been reported to reduce energy intake (EI) in humans, whereas few studies exist on… 
Highly Cited
2005
Highly Cited
2005
Effect of peptide YY3-36 on food intake in humans.
BACKGROUND & AIMS Studies in animals and humans suggest a role for peptide YY (PYY3-36) in regulating satiety. The physiologic… 
Highly Cited
2005
Highly Cited
2005
Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice.
Review
2005
Review
2005
Peptide YY, appetite and food intake
Obesity is taking on pandemic proportions. The laws of thermodynamics, however, remain unchanged, as energy will be stored if… 
Highly Cited
2004
Highly Cited
2004
Somatostatin infusion lowers plasma ghrelin without reducing appetite in adults with Prader-Willi syndrome.
Prader-Willi syndrome (PWS) is characterized by life-threatening childhood-onset hyperphagia, obesity and, uniquely, high plasma… 
Highly Cited
2003
Highly Cited
2003
Characterization of Blood-Brain Barrier Permeability to PYY3-36 in the Mouse
Peptide YY3-36 (PYY) has emerged as an important signal in the gut-brain axis, with peripherally administered PYY affecting… 
Highly Cited
1996
Highly Cited
1996
Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3–36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands
The peptide YY derivatives [Leu31,Pro34]PYY and PYY3–36 are highly selective Y1 and Y2 agonists, devoid of activity on the Y3… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)